Literature DB >> 25975874

Symbiotic and antibiotic interactions between gut commensal microbiota and host immune system.

Mantas Kazimieras Malys1, Laura Campbell2, Naglis Malys3.   

Abstract

The human gut commensal microbiota forms a complex population of microorganisms that survive by maintaining a symbiotic relationship with the host. Amongst the metabolic benefits it brings, formation of adaptive immune system and maintenance of its homeostasis are functions that play an important role. This review discusses the integral elements of commensal microbiota that stimulate responses of different parts of the immune system and lead to health or disease. It aims to establish conditions and factors that contribute to gut commensal microbiota's transformation from symbiotic to antibiotic relationship with human. We suggest that the host-microbiota relationship has been evolved to benefit both parties and any changes that may lead to disease, are not due to unfriendly properties of the gut microbiota but due to host genetics or environmental changes such as diet or infection.
Copyright © 2015 Lithuanian University of Health Sciences. Production and hosting by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  B-cells; Commensal microbiota; Dysbiosis; Immune system; T-cells

Mesh:

Substances:

Year:  2015        PMID: 25975874     DOI: 10.1016/j.medici.2015.03.001

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  9 in total

Review 1.  The role of intestinal microbiota in the pathogenesis of colorectal carcinoma.

Authors:  Jozef Kuzma; Dittmar Chmelař; Michal Hájek; Alexandra Lochmanová; Ivan Čižnár; Miroslav Rozložník; Miloslav Klugar
Journal:  Folia Microbiol (Praha)       Date:  2019-04-18       Impact factor: 2.099

Review 2.  GroEL-A Versatile Chaperone for Engineering and a Plethora of Applications.

Authors:  Maria S Yurkova; Alexey N Fedorov
Journal:  Biomolecules       Date:  2022-04-19

3.  Establishment and Development of the First Biobank of Inflammatory Bowel Disease, Suspected to Primary Immunodeficiency Diseases in Iran.

Authors:  Roya Sherkat; Soodabeh Rostami; Majid Yaran; Mohammad Hassan Emami; Hosein Saneian; Hamid Tavakoli; Peyman Adibi; Mahdieh Behnam; Saba Sheykhbahaei; Bahram Bagherpour; Razieh Khoshnevisan; Somayeh Najafi
Journal:  Adv Biomed Res       Date:  2018-03-27

4.  Neuroimmunology Research. A Report from the Cuban Network of Neuroimmunology.

Authors:  María de Los Angeles Robinson-Agramonte; Lourdes Lorigados Pedre; Orlando Ramón Serrano-Barrera
Journal:  Behav Sci (Basel)       Date:  2018-05-08

5.  The effects of antimicrobials and lipopolysaccharide on acute immune responsivity in pubertal male and female CD1 mice.

Authors:  Pasquale Esposito; Madeleine M Kearns; Kevin B Smith; Rajini Chandrasegaram; Anthony K Kadamani; Michelle Gandelman; Jacky Liang; Naghmeh Nikpoor; Thomas A Tompkins; Nafissa Ismail
Journal:  Compr Psychoneuroendocrinol       Date:  2022-06-11

6.  Phenylketonuria and Gut Microbiota: A Controlled Study Based on Next-Generation Sequencing.

Authors:  Felipe Pinheiro de Oliveira; Roberta Hack Mendes; Priscila Thiago Dobbler; Volker Mai; Victor Salter Pylro; Sheldon G Waugh; Filippo Vairo; Lilia Farret Refosco; Luiz Fernando Würdig Roesch; Ida Vanessa Doederlein Schwartz
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

7.  The Potential of Class II Bacteriocins to Modify Gut Microbiota to Improve Host Health.

Authors:  Özgün C O Umu; Christine Bäuerl; Marije Oostindjer; Phillip B Pope; Pablo E Hernández; Gaspar Pérez-Martínez; Dzung B Diep
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

8.  Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children.

Authors:  Shaaz Fareed; Neha Sarode; Frank J Stewart; Aneeq Malik; Elham Laghaie; Saadia Khizer; Fengxia Yan; Zoe Pratte; Jeffery Lewis; Lilly Cheng Immergluck
Journal:  PeerJ       Date:  2018-05-30       Impact factor: 2.984

9.  Marine Microalgae, Spirulina maxima-Derived Modified Pectin and Modified Pectin Nanoparticles Modulate the Gut Microbiota and Trigger Immune Responses in Mice.

Authors:  H P S U Chandrarathna; T D Liyanage; S L Edirisinghe; S H S Dananjaya; E H T Thulshan; Chamilani Nikapitiya; Chulhong Oh; Do-Hyung Kang; Mahanama De Zoysa
Journal:  Mar Drugs       Date:  2020-03-21       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.